IRMD IRADIMED
Health Care · Russell 2000
Next earnings: not announced yet
What 6 analyst firms say about IRADIMED: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
5 rated views · 6 analyst/firm records · 6 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (2)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (2)
Recent analyst activity · last 90 days
Our tracked history has 2 reports on IRMD from 2 analyst firms in the last 90 days (6 firms in the past year).
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Freedom Capital | Unnamed analyst | Buy | 2 Apr 2026 | — |
| Freedom Capital Markets | Ilya Zubkov | Buy | 2 Apr 2026 | 116.00 USD |
| Lake Street Capital Markets | Frank Takkinen | Buy | 11 Feb 2026 | 120.00 USD |
| Needham | David Saxon | Hold | 22 Sep 2026 | — |
| Roth Capital | Kyle Bauser | Buy | 10 Feb 2026 | 120.00 USD |
| Weiss Ratings | Unnamed analyst | — | 16 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:12 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.